After several months of scribbling these for the fellows and residents on the back of patient lists and notes, I decided to make a nicer version -Plus: does not require to understand my handwriting when reviewing #bcsm or writing notes- to share with them and 🩺

Methadone: A palliative care thread

Amazing 👏

☹☹

Hong Kong recorded another record daily high of new COVID-19 cases, as the city battles its worst outbreak since the pandemic began. abcn.ws/3HWWO1Z

ESMO's commitment to #CloseTheCareGap goes beyond #WorldCancerDay. The Society is committed to addressing inequalities in #cancercare and supporting the #ONEoncologycommunity. Learn more about ESMO's initiatives 👉 ow.ly/H3Tq50HXnoV

⭐️Darolutamide & Survival in Metastatic, Hormone-Sensitive Prostate Cancer NEJM 👉Darolutamide =Potent androgen-receptor ✅Risk of death lower, by 32.5%, in darolutamide vs placebo group (HR 0.68) ASCO #ASCOGU22 OncoAlert .nejm.org/doi/full/10.10…

uspharmacist.com/article/platin…

🆕 in Annals of Oncology an interesting Industry Corner Perspectives discussing “Paradigms for the development of transformative medicines - lessons from the #EGFR story” by W.Pao & Y.A. Nagel Roche #LCSM Highly recommended to read! annalsofoncology.org/article/S0923-…

A new generation of FGFR inhibitors emerged with Erdafitinib (approved in urothelial carcinoma), Pemigatinib (approved in cholangiocarcinoma) & Futibatinib (ph3 studies). Results of the phase I/II FIGHT-101 study of Pemigatinib in advanced malignancies 👇 annalsofoncology.org/article/S0923-…

⁦ESMO - Eur. Oncology⁩ Congress 2021: highlights from the ⁦EORTC⁩ #gastrointestinal tract #cancer group’s perspective. ⁦ESMO Open⁩ !! esmoopen.com/article/S2059-…

The easy trick to get positive results in a clinical trial is to make control arm underperform by substandard initial treatment or inferior treatment( sometimes repeating the same treatment) on progression. Congratulations Simon Van Wambeke Bishal Gyawali, MD, PhD, FASCO for pointing this out

“We should not consider the ARTA-ARTA sequence a SOC control arm going forward” . I Agree!! ascopubs.org/doi/full/10.12…

Requirements for successful drug development: 🔹Investigating fundamental biology 🔹Investigating disease biology in the context of treatment 🔹Developing new technologies You can learn more in this Industry Corner article in Annals of Oncology 👇 annalsofoncology.org/article/S0923-…

esmo.org/about-esmo/joi…

NATO Secretary General Jens Stoltenberg delivers remarks on the Russian invasion into Ukraine and whether NATO will consider using force cnn.it/3haELd1

U.S. Army soldiers in the 82nd Airborne Division in Poland will be deployed to the checkpoints at the border with Ukraine to help with a possible surge in the flow of traffic, a military source with direct knowledge told ABC News News. abcn.ws/3BOQEij

Ukraine declares martial law as Russia launches military operation hill.cm/jvkgO0V

Quebec Premier François Legault condemns ‘Russian aggression’ in Ukraine invasion dlvr.it/SKZhXY

As we prepare for a steep increase in #cancer incidence in LMICs, coupled with high drug costs, evidence-based, World Health Organization (WHO)-aligned, national essential medicines lists are powerful policy tools for cancer control planning. The Lancet Oncology @UICC bit.ly/3prKnnD